A
Financials

Abrdn Life Sciences Investors

HQL
Since

Headquarters:

PA, United States

Exchange:

NYSE

Industry:

Asset Management

Number of Employees:

N/A

Current Fiscal Year:

2025

Market Cap:

360.59M

Price per Share:

$12.85

Quarterly Dividend per Share:

$0.50
Year-to-date Performance:
-2.8723%
Dividend Yield:
%
Price-to-book Ratio:
0.78
Trailing P/E Ratio:
N/A

Price History

Latest Prices

DateOpenHighLowClose
2025-06-1312.8112.952712.7712.85
2025-06-1213.0213.0512.841212.98
2025-06-1113.0413.1212.930113.02
2025-06-1012.8613.029912.8612.94
2025-06-0912.7512.9112.7512.8

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Financial Performance

2025 Revenue:0.00

Detailed view of quarterly revenue

2025 Net Income:0.00

Detailed view of quarterly net income

2025 Free Cash Flow:0.00

Overview of free cash flow for the quarter

Annual Revenue Comparison

Compares total annual revenues

Similar Companies